SciELO - Scientific Electronic Library Online

 
vol.90 suppl.1El efecto de diferentes técnicas de anestesia sobre la oxigenación cerebral en cirugía torácicaTasas de readmisión de 90 días después de la colecistectomía: un estudio retrospectivo de cohort índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • No hay artículos similaresSimilares en SciELO

Compartir


Cirugía y cirujanos

versión On-line ISSN 2444-054Xversión impresa ISSN 0009-7411

Cir. cir. vol.90  supl.1 Ciudad de México jul. 2022  Epub 20-Ene-2023

https://doi.org/10.24875/ciru.21000373 

Original articles

Mechanisms of regenerative preconditioning in pigs with subtotal hepatectomies

Mecanismos del precondicionamiento regenerativo en hepatectomías subtotales en modelo porcino

Maitane I. Orue-Echebarria1  2  3 

Javier Vaquero3  4  5 

Elena Vara3  6 

Lisa Rancan3  6 

Pablo Lozano1  3 

Cristina J. Lisbona3  7 

Juan Laso3  7 

Carolina Fernández-Mena3  4 

Luis Olmedilla3  7 

Isabel Peligros3  8 

José L. García-Sabrido1  2  3 

José M. Asencio1  2  3  * 

1Department of General and Digestive Surgery, Transplant and Hepatobiliopancreatic Surgery Unit, Hospital General Universitario Gregorio Marañón

2Department of Surgery, School of Medicine, Universidad Complutense de Madrid

3Instituto de Investigación Sanitaria Gregorio Marañón

4HepatoGastro Lab, Hospital General Universitario Gregorio Marañón

5Centro de Investigaciones Biomédicas en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD)

6Department of Biochemistry and Molecular Biology, School of Medicine, Universidad Complutense de Madrid

7Department of Anaesthesiology, Hospital General Universitario Gregorio Marañón

8Department of Pathology, Hospital General Universitario Gregorio Marañón. Madrid, Spain


Abstract

Background:

Portal vein occlusion shortly before extended hepatic resections has hepatoprotective properties, but its molecular effects have not been elucidated. We characterized the impact of regenerative preconditioning by portal vein embolization (PVE) on hepatic energy metabolism and cytokine expression.

Materials and methods:

About 90% hepatectomies were performed in normal pigs (Control) and in pigs that underwent a PVE 24 h before the surgery (n = 10/group). Blood biochemistry and coagulation, liver damage, liver function (ICG), hepatic content of adenine nucleotides, and hepatic expression of inflammatory mediators (RT-PCR and WB) were determined before the hepatectomy, 15 min, and 24 h later.

Results:

All PVE and hepatectomies were successfully accomplished. The 90% hepatectomy resulted in: Immediate reduction of ATP, leading to persistent decreases of energy load and ATP/ADP ratio up to the 24-h time-point; and pro-inflammatory expression profile of cytokines in the remnant liver. Prior performance of PVE attenuated the bioenergetic alterations and prevented many of the changes in hepatic cytokine expression.

Conclusions:

Regenerative preconditioning by PVE improved hepatic energy metabolism and modulated inflammatory mediators in the remnant liver in pigs undergoing major hepatectomies, potentially contributing to its hepatoprotective effects.

Keywords Small-for-flow syndrome; Liver regeneration; Regenerative preconditioning; Cytokines; Energy metabolism

Resumen

Introducción:

la oclusión de la vena porta precoz antes de hepatectomías extendidas tiene propiedades hepatoprotectoras, pero sus efectos moleculares no se han aclarado. Caracterizamos el impacto del preacondicionamiento regenerativo por embolización de la vena porta (PVE) sobre el metabolismo energético hepático y la expresión de citocinas.

Materiales y métodos:

Realizamos hepatectomías del 90% en cerdos (Control) y en cerdos sometidos a PVE 24 horas antes de la cirugía (n = 10/grupo). La bioquímica y la coagulación, el daño hepático, la función hepática (ICG), los nucleótidos de adenina y la expresión de mediadores inflamatorios (RT-PCR y WB) fueron determinado antes de la hepatectomía, quince minutos y 24 horas después.

Resultados:

Las PVE y las hepatectomías se realizaron con éxito. La hepatectomía del 90% resultó en: una reducción del ATP, lo que disminuye la carga energética y la relación ATP/ADP a las 24 horas; y en la expresión de citocinas proinflamatorias. La realización previa de PVE atenuó las alteraciones bioenergéticas y evitó muchos de los cambios en la expresión de citocinas.

Conclusiones:

El preacondicionamiento regenerativo con PVE mejoró el metabolismo energético y moduló los mediadores inflamatorios en el hígado remanente en cerdos sometidos a hepatectomías subtotales, contribuyendo potencialmente a sus efectos hepatoprotectores.

Palabras clave Síndrome de “Small-for-Flow”; Regeneración hepática; Precondicionamiento Regenerativo; Citoquinas; Metabolismo energético

Introduction

The remarkable regenerative capacity of the liver makes the basis of modern liver surgery. The description of the small-for-size syndrome by Prof. Starzl in 1975 showed, however, that the liver regenerative capacity has certain limits1. Although the size of the remnant liver was identified as the primary determinant of the development of the post-hepatectomy liver failure that characterizes the small-for-size syndrome, the accumulated experience in both extended hepatectomies and liver transplantation with reduced grafts has progressively revealed the pathogenetic relevance of portal hyperafflux and portal pressure2.

The mechanisms by which the liver regenerates after a liver injury, be it an intoxication, an infection, or a resection of liver tissue, and how it may be therapeutically modulated, have not been fully established3,4. Regenerative preconditioning, a term coined by Nagano et al.5 relies on the concept that a liver with “activated” hepatocytes tolerates a mass resection better than a liver with hepatocytes in a “quiescent” state, representing a potential approach to prevent the post-hepatectomy liver failure. Portal vein ligation (PVL) or embolization (PVE) are well-known hepatocyte stimulation techniques employed to increase the size of the future liver remnant before extensive hepatic resections, but this strategy requires approximately 4 weeks before the hepatectomy can be performed6. Both PVL and PVE have also been used experimentally just 24-48 h before liver surgery, therefore, not involving pre-operative liver growth. In experimental studies, this regenerative preconditioning strategy was associated with improved tolerance to extended liver resections5,7. Hepatic induction of Klf2 and hepatic hemodynamic effects has been involved, but the operative mechanisms of regenerative preconditioning have not been fully elucidated.

Hepatic energy metabolism and inflammation-related signaling are two relevant processes for liver regeneration following hepatic resections. Release of ATP in liver sinusoids is one of the fasted events that occur after a resection of liver mass, and purinergic signaling has been involved in triggering liver regeneration8. Most studies have also found a decrease of mitochondrial oxidative phosphorylation at the early stages of liver regeneration, followed by a recovery over normal levels at later stages for fulfilling the increased energy demands imposed by the synthesis of new cellular components9. Similarly, cytokine signaling is a consistent observation early after the resection of liver mass, and it plays major roles in the early transcriptional response of hepatocytes, in sensitizing hepatocytes to adequately respond to growth factors later in the process, and in the acute phase response10,11. Both altered energy metabolism and disarranged inflammation have been linked to the development of failed liver regeneration and post-hepatectomy hepatic failure12,13. Notably, both processes are likely to be influenced by regenerative preconditioning induced by PVL or PVE14,15.

Here, we aimed to evaluate the effects of regenerative preconditioning by PVE on hepatic energy metabolism and inflammatory mediators in liver tissue in pigs undergoing subtotal hepatectomies 24 h after a PVE.

Materials and methods

Animals and experimental design

Twenty female swine, eight Large-white, and 12 Mini-pig, (body weight: 42.0 ± 2.0 kg) were divided in two groups (n = 10/group): a) the control group, in which swine underwent a subtotal 90% hepatectomy, and b) the PVE group, in which a PVE was performed 24 h before undergoing a subtotal 90% hepatectomy.

The study was approved by the Ethics Committee for Animal Experimentation of the General University Hospital Gregorio Marañón (Madrid, Spain) and of the Centro de Cirugía de Mínima Invasión Jesús Usón (Cáceres, Spain) and conformed to the European Union Regulations on animal experiments and with the “Guide for the care and use of laboratory animals” by the American Research Council, 2011 edition (https://www.nap.edu/download/12910) and the ARRIVE guidelines.

Only female animals were included in the study because of the anatomical differences in the genitourinary system; namely, the bladder and urethra extend along the midline in male pigs, which makes more difficult to perform a wide laparotomy.

Anesthetic and surgical protocol

We performed a subtotal 90% hepatectomy under general anesthesia with fentanyl (3 μg/kg i.v.), propofol (2–-4 mg/kg i.v.), and atracurium (0.6 mg/kg i.v.), following previously described protocols16. After the resection of liver mass, all animals were maintained anesthetized for 24 h until the end of the experiments. After 24 h of observation, a new laparotomy was performed to collect the tissue samples, and then the animals were euthanized with deep anesthesia and an intravenous bolus of potassium chloride. The measurement of liver function by the indocyanine green retention test and the collection of blood and tissue samples were performed at the beginning of the surgery before deresection of liver mass (Bas), and 15 min (T15m) and 24 h (T24h) after performing the subtotal 90% hepatectomy in conditions of hemodynamic stability. A more detailed description of the present experimental model can be found in a recent publication16.

Regenerative preconditioning by PVE

Based on the concept of regenerative preconditioning introduced by Nagano et al., we performed a PVE to stimulate hepatocyte proliferation in the future liver remnant. The PVE was performed by interventional radiology 24 h before undergoing the subtotal 90% hepatectomy. The embolization occluded 90% of the total liver mass, corresponding to the parenchyma that would later be resected, as previously described7.

Histological evaluation

Histological sections prepared from formalin-fixed paraffin-embedded liver tissue samples were stained with hematoxylin-eosin, and evaluated blindly by two pathologists (IP, ES). A score of histological damage was elaborated from seven parameters: congestion, hemorrhage, periportal edema, septal edema, endothelial detachment, necrosis, and apoptosis. Each parameter was scored: no damage (0), low (1), moderate (2), and severe (3). To give more weight to the parameters reflecting more acute damage, the final Histological Damage Score was calculated as S(congestion + 2*hemorrhage + periportal edema + septal edema + 2*endothelial detachment + 2*necrosis + 2*apoptosis). Therefore, the score ranged from 0 to 33 points, with a score ≥ 3 being considered histological damage.

Measurement of the protein expression of cytokines in liver tissue

We studied the expression of the following molecular mediators of inflammation: TNF-α, MCP-1, IL-1β IL-10, IL-4, IL-5, IL-6, and IL-8 following standard Western-blotting protocols using poly-acrylamide gel electrophoresis and nitrocellulose membranes (Bio-Rad, Mississauga, Ontario). Proteins were extracted after homogenizing and extracting flash-frozen liver tissue samples (50-60 mg) in buffer (100 mmol/L NaCl, 10 mmol/L TRIS-Cl (pH 7,6) 1 mmol/L EDTA (pH 8), and 1 mg/ml aprotinin, 100mg/ml PMSF). We used the following primary antibodies at 1:1.000 dilution: polyclonal rabbit anti-(rat) IL-1β (cat# 500-P80), IL-10 (cat# 500-P139), and TNF-α (cat# 0204M073RB) primary antibodies from Peprotech, monoclonal rabbit anti-(mouse) IL-6 (cat#12912) from cell signaling, polyclonal rabbit anti-MCP1 (cat# ab7814) from Abcam, and polyclonal rabbit anti-IL-4 (cat# 35227), anti-IL-5 (cat# 41062), and anti-IL-8 (cat# 41063) from Signalway Antibody LLC (College Park, MD, USA). Membranes were incubated with appropriate horseradish peroxidase-conjugated secondary antibodies (1:2000 dilution), and protein expression was detected using the ECL system (Amersham, Oakville, Ontario). Relative protein expression was determined using a scanner (BioRad GS 800) and the Quantity ONE 1.0 Analysis Software, versión 4.5.2.

Measurement of the mRNA expression of cytokines in liver tissue

The mRNA expression in the remnant liver tissue of the molecular mediators of inflammation TNF-α, MCP-1, IL-1β, and IL-10 was evaluated in a 7500 Fast Real-time PCR System (Applied Biosystems™) using commercially available reagents and primers validated for porcine genes from AnyGenes (Paris, France), following the manufacturer's instructions.

Concentration of adenine nucleotides in liver tissue

The concentration of ATP, the adenosine diphosphate (ADP), and the AMP was measured in flash-frozen tissue samples, which were lyophilized and stored at –80°C until biochemical determination.

ATP was measured by a spectrophotometric method based on the coupling of the ATP requiring 3-phosphoglycerate phosphorylation with an oxidation-reduction system (1,3-diphosphoglycerate/glyceraldehyde-3-P) involving a NAD+-linked enzyme. ATP was determined by measuring the decrease in absorbance at 340 nm. AMP was enzymatically converted to ADP, and ADP to ATP, by means of myokinase and pyruvate kinase, respectively.

The ratio ATP: ADP and the energy load were also calculated. For the energy load, the formula used was: (ATP + (ADP/2))/(ATP + ADP + AMP). Its value ranges from 0 (all AMP) to 1 (all ATP).

Statistical analysis

The statistical analysis was performed using the SPSS version 23.0 for Mac (IBM Corporation, Armonk, NY), and the graphs were created using GraphPad Prism for Windows v8.4.3 (GraphPad Software, LLC). The results were expressed as mean ± standard error of the mean. For the analysis of differences between groups, the mixed error-component model was used. With this model, we also looked for differences between groups in the 3-time points: Bas, T15m, and T24h. A p < 0.05 with a confidence level of 95% was considered statistically significant.

Results

General characteristics and outcomes of hepatic surgery

All PVE and the 90% hepatectomies were successfully completed. All animals were hemodynamically stable at the end of the surgery. Mortality after the 90% hepatectomy was similar in both groups (Control: 2 of 10 (20%) vs. PVE: 3 of 10 (30 %), p = 1.0). In the control group, one animal died in the immediate posterative time, and the other one died more than 12 h after surgery due to a cardiac embolism. Mortality in the PVE group occurred in three animals, all of them more than 12 h after the surgery.

Neither the PVE nor the subtotal hepatectomy induced major changes in circulating liver biochemistry markers (Table 1), except for a small increase of AST before the operation in the PVE group compared with the control group (p = 0.047). The circulating concentrations of ALT, AST, AP, and bilirubin tended to increase after the operation, but the changes were not statistically significant compared with baseline, and all of them were similar in the control and the PVE groups. Similarly, the INR tended to worsen at 24 h after the operation in both groups (p = 0.299).

Table 1 Evolution of blood laboratory parameters, liver function, and histological tissue damage in pigs of the control and the PVE groups undergoing a 90% hepatectomy 

Group Time point p

Bas T15m T24h
ALT (IU/l) Control 51.1 ± 8.8 37.7 ± 3.8 79.9 ± 15.9 0.445
PVE 40.7 ± 5.2 43.8 ± 3.9 48.8 ± 5.0
p 0.566 0.493 0.360
AST (IU/l) Control 60.8 ± 7.9 119.3 ± 24.2 617.9 ± 170.5 0.131
PVE 95.7 ± 13.9 177.5 ± 30.3 342.8 ± 65.4
p 0.047 0.092 0.161
AP (IU/l) Control 267 ± 56 255 ± 57 779 ± 167 0.149
PVE 299 ± 45 267 ± 31 670 ± 94
p 0.728 0.207 0.202
Bilirubin (mg/dl) Control 0.39 ± 0.10 0.51 ± 0.09 1.72 ± 0.21 0.564
PVE 0.25 ± 0.03 0.40 ± 0.06 1.35 ± 0.14
p 0.881 0.464 0.969
INR Control 0.90 ± 0.03 0.91 ± 0.03 1.94 ± 0.12 0.299
PVE 0.94 ± 0.05 0.90 ± 0.06 1.45 ± 0.10
p 0.439 0.605 0.30
Histological damage score Control 0.78 ± 0.36 5.89 ± 0.84 4.11 ± 0.87 0.123
PVE 1.40 ± 0.54 4.50 ± 0.50 3.00 ± 0.84
p 0.696 0.022 0.347
R15 Control 17.5 ± 3.4 52.1 ± 4.9 58.6 ± 4.1 0.028
PVE 13.7 ± 3.1 43.8 ± 12.2 61.9 ± 8.4
p 0.621 0.049 0.086

Values shown are mean ± SEM.

ALT: alanine amino transferase; AP: alkaline phosphatase; AST: aspartate amino transferase; Bas: baseline; INR: international normalized ratio; PVE: portal vein embolization;

R15: retention time 15 of indocyanine green; T15m: 15 min post-hepatectomy; T24h: 24 h post-hepatectomy

As in our prior study7, the 90% hepatectomy resulted in worsening of the histological damage score (Table 1), and the PVE had a slightly protective effect at the T15m time point (Control: 5.89 ± 0.84 vs. PVE: 4.50 ± 0.50, p = 0.022). Although the 90% hepatectomy worsened the indocyanine green R15 in both groups (p = 0.028, Table 1), liver function was slightly better in the PVE group compared with the control group at the T15m time-point (Control: 52.1 ± 4.9 vs. PVE: 43.8 ± 12.2, p = 0.049).

Changes in energy metabolism in liver tissue

The 90% hepatectomy had a drastic impact on hepatic energy metabolism, as assessed by the concentration of ATP, ADP, and AMP in the remnant liver tissue (Table 2). At baseline, the concentration of energy metabolites in liver tissue was similar in the control group and the PVE group, except for a small increase of AMP in the later (p = 0.009) The changes of energy metabolites became evident in both groups immediately after the resection of liver mass (T15m) and persisted up to the 24 h time point. They consisted of a decrease of ATP (p = 0.027) associated with concomitant increases of ADP (p = 0.003) and AMP (p < 0.001). Of note, the concentration of ATP was higher and the concentrations of ADP and AMP were lower in pigs of the PVE group compared with the control group at both the T15m and T24h time-points. Consequently, both groups presented important decreases of the ATP/ADP ratio and of the energy load immediately after the operation, but these calculated parameters were lower in pigs of the control group compared with pigs that underwent a PVE before the hepatic surgery (p < 0.001) (Fig. 1).

Table 2 Concentration of ATP, ADP and AMP in liver tissue from pigs of the Control and the PVE groups undergoing a 90% hepatectomy 

Group Time point p

Bas p (Bas-T15m) T15m p (Bas-T24h) H24
ATP (μmol/mg tissue) Control 4.06 ± 0.21 < 0.001 2.17 ± 0.05 < 0.001 1.18 ± 0.06 0.027
PVE 3.90 ± 0.17 2.78 ± 0.06 2.09 ± 0.03
p 0.573 <0.001 <0.001
ADP (μmol/mg tissue) Control 1.32 ± 0.07 < 0.001 2.81 ± 0.06 < 0.001 3.24 ± 0.08 0.003
PVE 1.37 ± 0.02 2.41 ± 0.01 2.87 ± 0.23
p <0.001 0.082 0.499
AMP (μmol/mg tissue) Control 0.85 ± 0.04 < 0.001 1.26 ± 0.04 < 0.001 1.90 ± 0.03 < 0.001
PVE 0.99 ± 0.02 1.04 ± 0.03 1.43 ± 0.12
p 0.009 0.001 0.001

Values shown are mean ± SEM. A mixed-model analysis was used to assess statistically significant differences between groups and time points.

Bas: baseline; PVE: portal vein embolization; T15m: 15 minutes post-hepatectomy; T24h: 24 hour post-hepatectomy.

Figure 1 Changes in ATP/ADP. A: ratio. B: energy load. After a 90% hepatectomy in normal pigs (Control group) and in pigs that underwent a PVE 24 h before the hepatic surgery (PVE group). The liver tissue samples were obtained just before the resection of liver mass (Bas), and at 15 min (T15m) and 24 h (T24h) later. The box and whiskers graphs show the mean ± the standard error of the mean. ***p < 0.001. 

Changes in inflammatory mediators in liver tissue

There were no changes of inflammatory mediators associated with the performance of the PVE, as assessed by the mRNA and protein expression of TNF-α, IL-1β, MCP-1, IL-10, IL-4, IL-5, IL-6, and IL-8 in liver tissue in the control and the PVE groups at baseline (Figs. 2 and 3, Table 3).

Figure 2 Densitometry analyses of Western-blots evaluating the expression. A: TNF-α. B: IL-1β. C: MCP-1. D: IL-10. E: IL-8 (E) proteins in the remnant liver tissue after a 90% hepatectomy in normal pigs (Control group) and in pigs that underwent a PVE 24 h before the hepatic surgery (PVE group). The liver tissue samples were obtained just before the resection of liver mass (Bas), and at 15 min (T15m) and 24 h (T24h) later. The box and whiskers graphs show the mean ± the standard error of the mean. *p < 0.05, **p < 0.01, ***p < 0.001. 

Figure 3 Real-time RT-PCR evaluation of the hepatic mRNA expression. A: TNF-α. B: IL-1β. C: MCP-1. D: IL-10. In the remnant liver tissue after a 90% hepatectomy in normal pigs (Control group) and in pigs that underwent a PVE 24 h before the hepatic surgery (PVE group). The liver tissue samples were obtained just before the resection of liver mass (Bas), and at 15 min (T15m) and 24 h (T24h) later. The box and whiskers graphs show the mean ± the standard error of the mean. *p < 0.05, **p < 0.01, ***p < 0.001. 

Table 3 Expression of pro-inflammatory and anti-inflammatory cytokines in liver tissue from pigs of the control and the PVE groups undergoing a 90% hepatectomy, as assessed by Western blotting 

Group Time point P

Bas p (Bas-T15m) T15m p (Bas-T24h) H24
TNF-α (densitometry units) Control 0.299 ± 0.043 0.002 0.845 ± 0.123 0.002 1.772 ± 0.232 0.012
PVE 0.338 ± 0.058 0.831 ± 0.074 0.569 ± 0.036
p 0.593 0.919 0.006
IL-1β (densitometry units) Control 0.330 ± 0.030 < 0.001 0.922 ± 0.956 < 0.001 1.797 ± 0.228 0.131
PVE 0.350 ± 0.068 0.791 ± 0.152 0.907 ± 0.063
p 0.794 0.480 0.119
MCP-1 (densitometry units) Control 0.931 ± 0.082 0.564 1.093 ± 0.087 0.002 1.705 ± 0.104 0.002
PVE 0.729 ± 0.058 0.868 ± 0.131 0.648 ± 0.084
p 0.067 0.180 <0.001
IL-10 (densitometry units) Control 4.538 ± 0.680 0.396 3.609 ± 0.320 0.034 1.962 ± 0.188 0.919
PVE 4.353 ± 0.331 3.623 ± 0.514 1.802 ± 0.008
p 0.811 0.981 0.344
IL-4 (densitometry units) Control 1.152 ± 0.312 0.234 0.917 ± 0.204 0.142 0.656 ± 0.135 0.816
PVE 1.289 ± 0.227 0.924 ± 0.104 0.701 ± 0.103
p 0.727 0.976 0.746
IL-5 (densitometry units) Control 1.474 ± 0.123 0.120 1.009 ± 0.134 0.268 1.215 ± 0.104 0.916
PVE 1.573 ± 0.252 1.141 ± 0.110 1.256 ± 0.007
p 0.730 0.462 0.881
IL-6 (densitometry units) Control 1.340 ± 0.100 0.094 1.812 ± 0.091 0.266 1.732 ± 0.284 0.886
PVE 1.211 ± 0.142 1.428 ± 0.402 1.298 ± 0.159
p 0.473 0.369 0.800
IL-8 (densitometry units) Control 9.786 ± 0.339 < 0.001 14.671 ± 0.612 0.006 15.372 ± 1.193 < 0.001
PVE 9.657 ± 0.666 9.530 ± 0.430 10.034 ± 0.027
p 0.866 <0.001 0.022

Values shown are mean ± SEM of densitometry analyses of the corresponding Western blots. A mixed-model analysis was used to assess statistically significant differences between groups and time points.

Bas: baseline; PVE: portal vein embolization; T15m: 15 min post-hepatectomy; T24h: 24 h post-hepatectomy.

The resection of liver mass induced the hepatic expression of TNF-α, IL-1β, and IL-8 proteins immediately after the hepatectomy (T15m), and they remained elevated 24 h later (Fig. 2 and Table 3). The protein expression of MCP-1 and IL-10 was unchanged at T15m, but MCP-1 increased and IL-10 decreased at 24 h after the hepatectomy. Importantly, the changes of TNF-ba, MCP-1, and IL-8 were significantly attenuated or completely prevented in the group of pigs undergoing PVE before the 90% hepatectomy, with the effect on IL-8 being noted already at the early T15m time-point. The hepatic expression of IL-4, IL-5, and IL-6, however, was not affected either by the PVE nor by the resection of liver mass.

In addition to protein expression, we also determined the impact of PVE and 90% hepatectomy on the mRNA expression of TNF-α, IL-1β, MCP-1, and IL-10 (Fig. 3). The genetic expression of these inflammatory mediators was mostly in accordance with the findings of their protein expression. Furthermore, the real-time RT-PCR analyses of liver tissue revealed significantly lower expressions of IL-1βeta mRNA at T15m and T24h and of IL-10 mRNA at T24h in the PVE group compared with the control group, which had not been detected at the protein level.

Discussion

The previous studies have reported beneficial hemodynamic, analytical, and histological effects of regenerative preconditioning induced by the occlusion of portal vein in animals undergoing extended resections of liver mass5,7, but its effects on molecular pathways relevant for liver regeneration still need to be elucidated. In the present study, we evaluated the changes on hepatic energy metabolism and inflammatory mediators that resulted from regenerative preconditioning induced by PVE performed 24 h before a subtotal 90% hepatectomy in pigs. We found that regenerative preconditioning by PVE attenuated the deterioration of hepatic energy metabolism and the elevation of pro-inflammatory cytokines in the remnant liver as early as 15 min after the resection of liver mass, which was associated with slight improvements of liver pathology and liver function as assessed by liver histology and the indocyanine green retention test, respectively.

A number of studies have reported considerable changes of the concentration of adenine nucleotides and other energy compounds after a resection of liver mass. Such changes differ depending on the time interval from the surgical operation as well as on the extent of the hepatic resection. After the resection of liver mass, an early, almost immediate, drastic decrease of the hepatic concentration of total adenine nucleotides, not necessarily associated with energy consumption or mitochondrial impairment, has been mainly related with the release of ATP by hepatocytes and non-parenchymal cells, and it appears to constitute a relevant trigger for liver regeneration8,9,17. Increased energy consumption or bioenergetic impairment at this stage, manifested as decreases of ATP with parallel increases of ADP and AMP or as mitochondrial dysfunction, however, has been related with extended hepatic resections or other conditions associated with impaired hepatocyte proliferation or impending liver failure12,15,18,19. As in prior studies and consistent with the development of post-hepatectomy liver failure, pigs undergoing 90% hepatectomies presented an immediate decrease of ATP associated with concomitant increases of ADP and AMP, resulting in decreases of the energy load and of the ATP/ADP ratio that persisted up to the 24-h time point. Although it did not prevent them, regenerative preconditioning by PVE significantly attenuated these changes, supporting the improvement of mitochondrial function observed in prior studies in rats with a similar approach14.

The impact on the expression of inflammatory mediators in the liver tissue remnant was a second major effect of regenerative preconditioning by PVE noted in the present study. Although cytokine activation and signaling plays a pivotal role in the normal recovery of liver mass, an excessive or aberrant production of inflammatory mediators leads to liver damage and is detrimental for liver regeneration, as it has been observed in many pathologic processes13,20-23. Here, the resection of liver mass led to an induction of pro-inflammatory (TNF-α, IL-1β, MCP-1, and IL-8) and a decrease of anti-inflammatory (IL-10) proteins. The fact that most of these changes were observed at both the mRNA and the protein level, and that other mediators (IL-4, IL-5, and IL-6) remained unchanged, provided consistency to our observations. Regenerative preconditioning by PVE was associated with a partial attenuation or even complete prevention of some of those changes. The prevention of the induction of IL-1β mRNA and of IL-8 protein was observed almost immediately after the resection of liver mass, suggesting a potential mechanism by which regenerative preconditioning may diminish the development of post-hepatectomy liver failure. The mechanistic relevance of other effects of regenerative preconditioning that were observed at 24 h, for example, the attenuation of the increases of TNF-α, MCP-1, and IL-8, is less straightforward. A survival bias is unlikely to explain the difference between the control and the PVE groups because mortality was similar in both groups, but the changes observed still may be the consequence rather than the cause of decreased liver damage. Nonetheless, attenuation of the expression of these mediators has been shown to decrease liver damage in other studies22-24.

Conclusion

In conclusion, performance of subtotal hepatectomies leading to the small-for-flow syndrome in pigs was characterized by severe hepatic energy impairment and by the induction of a pro-inflammatory state in the remnant liver. Regenerative preconditioning by PVE improved energy metabolism and attenuated the expression of pro-inflammatory cytokines in the remnant liver tissue, suggesting potential hepatoprotective mechanisms of this strategy.

References

1. Starzl TE, Putnam CW, Groth CG, Corman JL, Taubman J. Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection. Am J Surg. 1975;129:587-90. [ Links ]

2. Asencio JM, Vaquero J, Olmedilla L, García Sabrido JL. “Small-for-flow“syndrome:shifting the “size“paradigm. Med Hypotheses. 2013;80:573-7. [ Links ]

3. Cienfuegos JA, Rotellar F, Baixauli J, Martínez-Regueira F, Pardo F, Hernández-Lizoáin JL. Liver regeneration--the best kept secret. A model of tissue injury response. Rev Esp Enferm Dig. 2014;106:171-94. [ Links ]

4. Tao Y, Wang M, Chen E, Tang H. Liver regeneration:analysis of the main relevant signaling molecules. Mediators Inflamm. 2017;2017:4256352. [ Links ]

5. Nagano Y, Nagahori K, Kamiyama M, Fujii Y, Kubota T, Endo I, et al. Improved functional reserve of hypertrophied contra lateral liver after portal vein ligation in rats. J Hepatol. 2002;37:72-7. [ Links ]

6. Clavien PA, Petrowsky H, DeOliveira ML, Graf R. Strategies for safer liver surgery and partial liver transplantation. N Engl J Med. 2007;356:1545-59. [ Links ]

7. Asencio JM, García-Sabrido JL, López-Baena JA, Olmedilla L, Peligros I, Lozano P, et al. Preconditioning by portal vein embolization modulates hepatic hemodynamics and improves liver function in pigs with extended hepatectomy. Surgery. 2017;161:1489-501. [ Links ]

8. Gonzales E, Julien B, Serrière-Lanneau V, Nicou A, Doignon I, Lagoudakis L, et al. ATP release after partial hepatectomy regulates liver regeneration in the rat. J Hepatol. 2010;52:54-62. [ Links ]

9. Kamiyama Y, Ozawa K, Honjo I. Changes in mitochondrial phosphorylative activity and adenylate energy charge of regenerating rabbit liver. J Biochem. 1976;80:875-81. [ Links ]

10. Fausto N, Campbell JS, Riehle KJ. Liver regeneration. J Hepatol. 2012;57:692-4. [ Links ]

11. Li W, Liang X, Leu JI, Kovalovich K, Ciliberto G, Taub R. Global changes in interleukin-6-dependent gene expression patterns in mouse livers after partial hepatectomy. Hepatology. 2001;33:1377-86. [ Links ]

12. Alexandrino H, Varela AT, Teodoro JS, Martins MA, Rolo AP, Tralhão JG, et al. Mitochondrial bioenergetics and posthepatectomy liver dysfunction. Eur J Clin Invest. 2016;46:627-35. [ Links ]

13. Taub R. Liver regeneration in health and disease. Clin Lab Med. 1996;16:341-60. [ Links ]

14. Katoh T, Tanaka M, Nimura Y, Kanai M, Nagino M, Ozawa T. Enhancement of rat liver mitochondrial function by portal branch ligation secures subsequent extended hepatectomy. Biochem Int. 1991;24:107-16. [ Links ]

15. Budai A, Horváth G, Tretter L, Radák Z, Koltai E, Bori Z, et al. Mitochondrial function after associating liver partition and portal vein ligation for staged hepatectomy in an experimental model. Br J Surg. 2019;106:120-31. [ Links ]

16. Orue-Echebarria MI, Vaquero J, Lisbona CJ, Lozano P, Steiner MA, Morales A, et al. Comprehensive characterization of a porcine model of the “small-for-flow“syndrome. J Gastrointest Surg. 2019;23:2174-83. [ Links ]

17. Crumm S, Cofan M, Juskeviciute E, Hoek JB. Adenine nucleotide changes in the remnant liver:an early signal for regeneration after partial hepatectomy. Hepatology. 2008;48:898-908. [ Links ]

18. Martins RM, Teodoro JS, Furtado E, Rolo AP, Palmeira CM, Tralhão JG. Evaluation of bioenergetic and mitochondrial function in liver transplantation. Clin Mol Hepatol. 2019;25:190-8. [ Links ]

19. Dold S, Richter S, Kollmar O, von Heesen M, Scheuer C, Laschke MW, et al. Portal hyperperfusion after extended hepatectomy does not induce a hepatic arterial buffer response (HABR) but impairs mitochondrial redox state and hepatocellular oxygenation. PLoS One. 2015;10:e0141877. [ Links ]

20. Wang H, Park O, Lafdil F, Shen K, Horiguchi N, Yin S, et al. Interplay of hepatic and myeloid signal transducer and activator of transcription 3 in facilitating liver regeneration via tempering innate immunity. Hepatology. 2010;51:1354-62. [ Links ]

21. Mohammed FF, Smookler DS, Taylor SE, Fingleton B, Kassiri Z, Sanchez OH, et al. Abnormal TNF activity in Timp3-/-mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet. 2004;36:969-77. [ Links ]

22. Czaja MJ, Xu J, Alt E. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology. 1995;108:1849-54. [ Links ]

23. Zamara E, Galastri S, Aleffi S, Petrai I, Aragno M, Mastrocola R, et al. Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice. J Hepatol. 2007;46:230-8. [ Links ]

24. Kato A, Yoshidome H, Edwards MJ, Lentsch AB. Reduced hepatic ischemia/reperfusion injury by IL-4:potential anti-inflammatory role of STAT6. Inflamm Res. 2000;49:275-279. [ Links ]

FundingThe authors declare that the making of this article was supported by grants from the Sociedad Española de Trasplante Hepático (SETH) to J.M.A and from Instituto de Salud Carlos III-Fondos FEDER “Una manera de hacer Europa” (PI15/1083) to JV. CFM was supported by an internal fellowship from Instituto de Investigación Sanitaria Gregorio Marañón.

Ethical disclosures

Protection of human and animal subjects. The authors declare that the procedures followed were in accordance with the regulations of the relevant clinical research ethics committee and with those of the Code of Ethics of the World Medical Association (Declaration of Helsinki).

Confidentiality of data. The authors declare that no patient data appear in this article.

Right to privacy and informed consent. The authors declare that no patient data appear in this article.

Received: April 25, 2021; Accepted: August 11, 2021

* Correspondence: José M. Asencio c/Doctor Esquerdo 46, C.P. 28007 Madrid, Spain. E-mail: jmasencio@gmail.com

Conflicts of interest

The authors declare no conflicts of interest.

Creative Commons License Instituto Nacional de Cardiología Ignacio Chávez. Published by Permanyer. This is an open access article under the CC BY-NC-ND license